Medpace Holdings, Inc. Common Stock (MEDP) is a publicly traded Healthcare sector company. As of May 21, 2026, MEDP trades at $422.00 with a market cap of $12.01B and a P/E ratio of 25.82. MEDP moved +0.51% today. Year to date, MEDP is -28.11%; over the trailing twelve months it is +37.59%. Its 52-week range spans $250.05 to $628.92. Analyst consensus is buy with an average price target of $447.50. Rallies surfaces MEDP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Medpace climbs as Q1 beat and FY2026 outlook keep buyers active: Medpace shares rose about 3% on May 5, 2026 as investors continued to position for follow-through after the company’s April 22 Q1 beat and upbeat full-year 2026 outlook. The quarter showed revenue of $706.6 million and GAAP EPS of $4.28, keeping attention on growth momentum despite a sub-1.0 net book-to-bill of 0.88.
| Metric | Value |
|---|---|
| Price | $422.00 |
| Market Cap | $12.01B |
| P/E Ratio | 25.82 |
| EPS | $16.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $628.92 |
| 52-Week Low | $250.05 |
| Volume | 333.70K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.68B |
| Net Income | $460.40M |
| Gross Margin | 29.07% |
8 analysts cover MEDP: 0 strong buy, 3 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $447.50.